Trade now with Barclays Stockbrokers
11-Apr-25 |
Transfer From |
Giles Wilson |
0.000p | 297 |
£0.00 |
11-Apr-25 |
Buy |
Giles Wilson |
50.55p | 297 |
£150.13 |
08-Apr-25 |
Buy |
Giles Wilson |
46.92p | 58 |
£27.21 |
25-Mar-25 |
Buy |
Giles Wilson |
54.01p | 32,640 |
£17,628.31 |
25-Mar-25 |
Buy |
Giles Wilson |
54.01p | 32,640 |
£17,628.31 |
11-Apr-25 |
Buy |
Giles Wilson |
50.55p | 297 |
£150.13 |
08-Apr-25 |
Buy |
Giles Wilson |
46.92p | 58 |
£27.21 |
11-Apr-25 |
Transfer From |
Giles Wilson |
0.000p | 297 |
£0.00 |
Kenny Wilson |
11,513,363 |
£6,079,056 |
Paul Mason |
7,875,000 |
£4,158,000 |
Giles Wilson |
110,191 |
£58,181 |
Robyn Perriss |
94,328 |
£49,805 |
Andrew Harrison |
76,594 |
£40,442 |
Lynne Weedall |
40,054 |
£21,148 |
Ian Rogers |
20,270 |
£10,703 |
IngreLux S.àr.l |
369,942,440 |
£195,329,608 |
IngreGrsy Limited |
369,942,440 |
£195,329,608 |
Permira Holdings Limited |
364,142,440 |
£192,267,208 |
Artemis Investment Management LLP |
86,997,521 |
£45,934,691 |
Fidelity Management & Research |
32,500,000 |
£17,160,000 |
Intertrust Employee Benefit Trustee Limited |
135,000 |
£71,280 |
|
Interim |
Final |
Ex-Div |
06-Mar-25 |
29-Aug-24 |
Paid |
08-Apr-25 |
01-Oct-24 |
Amount |
0.85p |
0.99p |
16:35 |
179,183 @ 52.80p |
16:35 |
1 @ 52.80p |
16:35 |
1,726 @ 52.80p |
16:35 |
713 @ 52.80p |
16:35 |
4,765 @ 52.80p |
Chair |
Paul Mason |
CEO |
Kenny Wilson |
CFO |
Giles Wilson |
Top of Page
You are here:
research